Regulatory filing 📈 Stocks 🌍 United States

AtlasClear Holdings Suspended by NYSE American, Plans Appeal to Delisting

AtlasClear Holdings is appealing an NYSE American delisting notice triggered by low share prices, with plans to move to the OTC market while pursuing a potential reverse stock split to regain compliance.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 1 Bearish, 0 Neutral. Strongest signal: ATCH ↓ 8/10 (85% confidence).

📊 Affected Assets (1)

ATCH
Bearish 🤖 85%
📅 Short-term 🌍 US · Explicit

NYSE American suspended trading in the common stock effective November 10, 2026 and began delisting proceedings under Section 1003(f)(v) based on the low selling price. The stock is expected to move to the OTC market under 'ATCH' during the appeal, which typically costs liquidity, visibility and institutional ownership. The company plans an appeal and a possible reverse split, and cites 85% fiscal 2026 revenue growth to $20.1 million and cash of $15.4 million, but there is no assurance the appeal succeeds or that an active OTC market develops.

Catalysts
  • ▼ Trading suspension effective immediately on November 10, 2026 and commencement of delisting proceedings
  • ▼ Expected move of the quote to the OTC market under 'ATCH' during the appeal
Risk Factors
  • ▲ Company states AtlasClearing remains compliant with regulatory net capital requirements and clearing operations continue in the ordinary course
  • ▲ Fiscal 2026 revenue increased 85% to $20.1 million and cash more than doubled to $15.4 million without an at-the-market offering

🧭 Full analysis of these assets

🎯 Key Takeaways

  • NYSE American suspended trading of AtlasClear Holdings effective November 10, 2026, citing Section 1003(f)(v) regarding low share price.
  • The company reported fiscal 2026 revenue of $20.1 million, an 85% increase, with cash reserves reaching $15.4 million.
  • AtlasClear has signed eight correspondent broker-dealer agreements and remains compliant with regulatory net capital requirements.
  • Management plans to appeal the delisting and is considering a reverse stock split to support continued listing.

📝 Executive Summary

AtlasClear Holdings faces immediate trading suspension on the NYSE American due to its low share price. The company intends to appeal the delisting proceedings and expects its stock to trade on the OTC market under the symbol ATCH during the process. Despite the exchange action, management reports fiscal 2026 revenue grew 85% to $20.1 million, with $15.4 million in cash, and maintains that clearing operations remain fully compliant.

❓ FAQ

Can I still sell my AtlasClear shares?

Trading on NYSE American is suspended, but the company expects the stock to be quoted on the OTC market under the symbol 'ATCH' during the appeal, so shareholders can trade there. The company cautions that no active OTC market is guaranteed.

Does the delisting proceeding mean the business is failing?

The article states the Exchange's determination is based solely on the low selling price of the stock, not on operations or regulatory capital, and that AtlasClearing remains compliant with its net capital requirements with revenue up 85% to $20.1 million in fiscal 2026.